Sagimet Biosciences
Develops oral FASN inhibitor drugs for metabolic and inflammatory diseases.
Company facts
- Founded
- 2006
- Employees
- 24
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq: SGMT
Develops oral FASN inhibitor drugs for metabolic and inflammatory diseases.
Company facts